Main Library
About 83% of life sciences and healthcare C-suite executives say that improving health equity is a top-10 goal in 2024, according to a recent report from Deloitte. In addition, 47% anticipate increasing health equity investments in 2024.
“While most industry leaders we have spoken to see value in ensuring that everyone has access to high-quality health care, realizing a return on the investment (ROI) requires an intentional strategy and time,” the report said. “In the short term, health equity investments could impact the nature of competition if it has a favorable effect on recruitment, retention, or operations. In the long-term, health equity can affect every aspect of business—from an organization’s workforce to its products and services. It can be the differentiator in value and growth.”